Clinical trial · Interventional
Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study
Prospective Controlled Randomized Feasibility Study on a Treatment With Viscum Album in Patients With Breast Cancer to Identify Appropriate Surrogate Parameters for a Randomized Study of the Efficacy of Treatment With Mistletoe Extracts
NCT00176046CI-TRIAL-00027395completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this feasibility study is to identify appropriate surrogate parameters for a randomized study to examine the efficacy of a complementary therapy with an extract of viscum album (Iscador P) in patients with breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastatic Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| viscum album pini | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- viscum album pini
- description
- immediate start of treatment with Iscador P s.c.
- interventionNames
- Drug: viscum album pini
- type
- ACTIVE_COMPARATOR
- label
- waiting group
- description
- identical treatment with Iscador P s.c. after waiting period of 3 months
- interventionNames
- Drug: viscum album pini
Primary outcomes (7)
- measure
- blood count
- timeFrame
- 6-30 months
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * breast cancer * desire for additional therapy with mistletoe extracts Exclusion Criteria: * contraindication for a therapy with mistletoe extracts(allergy, tuberculosis, hyperthyreosis, acute infectious disease, intracranial pressure in case of tumors or metastasis) * current medication with glucocorticoids or other immunosuppressive therapies * other concomitant complementary therapies * prior therapy with mistletoe extracts \> 2 years or during the last 6 months * karnofsky-Index \<60
References
Publications (0)
Data not yet available
No reference posted for this study.